Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.
Ynke LarivièreIrene Garcia-FogedaTrésor Matuvanga ZolaBernard Isekah Osang'irSolange MiloloRachel MetaPrimo KimbuluCynthia RobinsonMichael KatwereChelsea M McLeanNiel HensJunior Rika MatangilaVivi MaketaPatrick MitashiHypolite Mavoko MuhindoJean-Pierre Van GeertruydenPierre van DammePublished in: The Journal of infectious diseases (2023)
The 2-dose vaccine regimen was well tolerated and led to a high antibody response among fully vaccinated health care providers and frontliners in Boende.